The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position

Ji Young Mun, Robert W. Kensler, Samantha P. Harris, Roger Craig

Research output: Contribution to journalArticlepeer-review

15 Scopus citations


Mutations in cardiac myosin binding protein C (cMyBP-C), a thick filament protein that modulates contraction of the heart, are a leading cause of hypertrophic cardiomyopathy (HCM). Electron microscopy and 3D reconstruction of thin filaments decorated with cMyBP-C N-terminal fragments suggest that one mechanism of this modulation involves the interaction of cMyBP-C's N-terminal domains with thin filaments to enhance their Ca2+-sensitivity by displacement of tropomyosin from its blocked (low Ca2+) to its closed (high Ca2+) position. The extent of this tropomyosin shift is reduced when cMyBP-C N-terminal domains are phosphorylated. In the current study, we have examined L348P, a sequence variant of cMyBP-C first identified in a screen of patients with HCM. In L348P, leucine 348 is replaced by proline in cMyBP-C's regulatory M-domain, resulting in an increase in cMyBP-C's ability to enhance thin filament Ca2+-sensitization. Our goal here was to determine the structural basis for this enhancement by carrying out 3D reconstruction of thin filaments decorated with L348P-mutant cMyBP-C. When thin filaments were decorated with wild type N-terminal domains at low Ca2+, tropomyosin moved from the blocked to the closed position, as found previously. In contrast, the L348P mutant caused a significantly larger tropomyosin shift, to approximately the open position, consistent with its enhancement of Ca2+-sensitization. Phosphorylated wild type fragments showed a smaller shift than unphosphorylated fragments, whereas the shift induced by the L348P mutant was not affected by phosphorylation. We conclude that the L348P mutation causes a gain of function by enhancing tropomyosin displacement on the thin filament in a phosphorylation-independent way.

Original languageEnglish (US)
Pages (from-to)141-147
Number of pages7
JournalJournal of Molecular and Cellular Cardiology
StatePublished - Feb 1 2016


  • CMyBP-C
  • Cardiac muscle
  • Electron microscopy
  • Hypertrophic cardiomyopathy
  • Myosin binding protein C
  • Thin filament

ASJC Scopus subject areas

  • Molecular Biology
  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'The cMyBP-C HCM variant L348P enhances thin filament activation through an increased shift in tropomyosin position'. Together they form a unique fingerprint.

Cite this